Skip to content

Clinical research on the treatment of the less menstrual volume caused by endometrial damage by using the methods of invigorating kidney and promoting blood circulation, supplementing qi and activating blood

Clinical research on the treatment of the less menstrual volume caused by endometrial damage by using the methods of invigorating kidney and promoting blood circulation, supplementing qi and activating blood

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010939
Enrollment
Unknown
Registered
2017-03-21
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intimal injury

Interventions

Experimental group:Using Bushen Huoxue, Yiqi Shengji decoction
Control group:Progynova + Duphaston

Sponsors

Longhua hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 18-40 years old; (2) Meet the diagnostic criteria of less menstrual volume; (3) Patients with menstrual cycle rules and has ovulation; (4) Has the operation history of uterine cavity operation (artificial abortion, curettage and diagnostic curettage of uterus); (5) endometrial <8mm thick one week after the ovulation; (6) Endocrine factors have been ruled out due to less menstrual volume; (7) Informed consent to participate in this research voluntarily.

Exclusion criteria

Exclusion criteria: (1) Allergic constitution or patients who is allergic to known pharmaceutical ingredients; (2) Combined with uterine fibroids, ovarian tumors or genital Malformations; (3) Patients who had been diagnosed with cervical or intrauterine adhesions by iodized oil or hysteroscopy (4) Less menstrual volume caused by endometrial tuberculosis, pituitary adenoma, thyroid disease, etc; (5) Combined with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system of severe primary disease (6) People who is unable to cooperate, such as having a neurological disorder or mental disease, or unwilling to cooperate; (7) Similar drugs have been used in the past three months, such as taking related drugs or antagonistic drugs, which might cause difficulty of judging the drugs efficacy; (8) Patients not signed the informed consent.

Design outcomes

Primary

MeasureTime frame
Uterine accessories ultrasound;menstrual blood volume;

Secondary

MeasureTime frame
Blood routine;

Countries

China

Contacts

Public ContactLI JI

Longhua hospital affiliated to Shanghai University of Traditional Chinese Medicine

drliji@163.com+86 18917763030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026